24 January 2025 | News
Expansion will transform Peenya into a key manufacturing hub for the Asia Pacific region
Merck Life Science in India has recently announced the expansion of its manufacturing facility in Peenya, Bengaluru, marking a significant milestone in its strategy.
The expansion will transform Peenya into a key manufacturing hub for the Asia Pacific (APAC) region, strengthening Merck’s capabilities in production and supporting the growing needs of its customers worldwide.
To commemorate this milestone, Merck hosted an inaugural ceremony at the Peenya site, bringing together company leadership, customers and key stakeholders.
Senior leaders including, Tony Qiu, Head of APAC Region, Global Plant Operations, ISCO, Merck Life Science; Prasanna NK, Site Director- Peenya, Bengaluru, Merck Life Science; Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; and Dhananjay Singh, Managing Director of Merck Life Science shared insights on the expansion project and emphasised the importance of building sustainable capabilities in Asia and India for future growth.
The Peenya facility expansion also reflects Merck's ongoing commitment towards India and supporting the government’s "Make in India" initiative. This move reinforces Merck’s dedication to manufacturing world-class, globally compliant products in India.